Literature DB >> 216840

Immunohistologic evaluation of the lymphoreticular infiltrate of human central nervous system tumors.

G W Wood, R A Morantz.   

Abstract

Forty-five nervous system tumors (9 glioblastomas, 9 meningiomas, 15 assorted primary neural tumors including 3 medulloblastomas, and 12 brain tumors metastatic to the brain were analyzed for their content of lymphocytes, granulocytes, and macrophages. Cell suspensions were prepared by enzymatic digestion; lymphocytes and granulocytes were quantitated by morphology following cytocentrifugation, and macrophages were quantitated by IgG EAC (erythrocyte-antibody-complement) rosette formation. EA (erythrocyte-antibody) adsorption to sections of tumor was employed to determine the distribution of the IgG Fc receptor-positive cells within the tumors and to serve as quality control for selective release of Fc receptor-positive cells by enzyme digestion. The 9 glioblastomas had a mean macrophage content of 41% (range: 5-78%); the 9 meningiomas, 42% (range: 5-80%); the 3 medulloblastomas, 6% (range: 2-15%); and the metastatic tumors, 21% (range: 2-50%). Lymphocyte contents were variable but generally less than 10%. Most tumors contained less than 10% granulocytes. EA adsorption demonstrated that Fc receptor-positive cells were distributed throughout the tumor mass, although different types of patterns were observed. There was an excellent correlation between the percent EAC rosette-positive cells in suspensions and the extent of EA adsorption to the tumor sections. The significance of the study primarily rests in the demonstration that most nervous system tumors contain high numbers of infiltrating host cells, primarily macrophages.

Entities:  

Mesh:

Year:  1979        PMID: 216840     DOI: 10.1093/jnci/62.3.485

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  23 in total

1.  Immunocytochemical study of the cellular immune response in meningiomas.

Authors:  M L Rossi; F Cruz Sanchez; J T Hughes; M M Esiri; H B Coakham
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

2.  Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?

Authors:  Thomas N Seyfried; Laura Shelton; Gabriel Arismendi-Morillo; Miriam Kalamian; Ahmed Elsakka; Joseph Maroon; Purna Mukherjee
Journal:  Neurochem Res       Date:  2019-04-25       Impact factor: 3.996

3.  Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation.

Authors:  T Morimura; C Neuchrist; K Kitz; H Budka; O Scheiner; D Kraft; H Lassmann
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  Detection of lymphocytes in malignant gliomas by monoclonal antibodies.

Authors:  K Yasuda; T Alderson; J Phillips; K Sikora
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-08       Impact factor: 10.154

Review 5.  Immunobiologic aspects of the brain and human gliomas. A review.

Authors:  C J Wikstrand; D D Bigner
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

6.  Immunohistological study of mononuclear cell infiltrate in malignant gliomas.

Authors:  M L Rossi; J T Hughes; M M Esiri; H B Coakham; D B Brownell
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

Review 7.  Invasiveness of primary brain tumors.

Authors:  O D Laerum; R Bjerkvig; S K Steinsvåg; L de Ridder
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

Review 8.  Macrophages and neoplasms: new insights and their implication in tumor immunobiology.

Authors:  R Evans
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

9.  Mononuclear cell infiltrate and HLA-DR expression in low grade astrocytomas. An immunohistological study of 23 cases.

Authors:  M L Rossi; F Cruz-Sanchez; J T Hughes; M M Esiri; H B Coakham; T H Moss
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

10.  Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model.

Authors:  P Mukherjee; M M El-Abbadi; J L Kasperzyk; M K Ranes; T N Seyfried
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.